SenesTech

SNES NASDAQ
1.270
-0.010
-0.78%
Closed 16:00 08/20 EDT
Open
1.280
Prev Close
1.280
High
1.288
Low
1.230
Volume
49.94K
Avg Vol (3M)
194.15K
52 Week High
1.950
52 Week Low
0.5500
% Turnover
0.18%
Market Cap
36.21M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers SenesTech SNES stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

SenesTech, Inc. is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility control. It offers ContraPest, a fertility control product candidate. ContraPest's technology and approach targets the reproductive capabilities of both sexes. Using bait stations, ContraPest is dispensed in a palatable liquid formulation that promotes sustained consumption by rodent communities. Its formulation causes both female and male rats to become infertile once they have consumed the dose. The active ingredient in females accelerates the rate at which ovarian follicles (egg structures) are depleted. Once these cells are gone, the animal cannot reproduce. In males, there is a marked reduction in the ability to fertilize eggs and, often complete sterility. ContraPest is designed, formulated and dispensed for handlers and non-target species, such as wildlife and pets in a biodegradable product.
MORE >

Recently

Name
Price
%Change